1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kazakhstan Pharmaceuticals and Healthcare Report Q1 2016

Kazakhstan Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 76 pages

Includes 3 FREE quarterly updates

BMI View: Kazakhstan's pharmaceutical market will continue to grow at a rapid pace over our forecastperiod Its accession into the Eurasian Economic Union (EAEU) will lead to access to better quality drugsat lower prices, increasing consumption as the country forms and integrates a common market forpharmaceuticals Government expenditure on health continues to play a key role in boosting medicineconsumption However, unless the government steps up economic diversification and decreases its relianceon the oil sector, we doubt it will be able to sustain its current level of spending over the long-term

Headline Expenditure Projections

- Pharmaceuticals: KZT31005bn (USD173bn) in 2014 to KZT34957bn (USD161bn) in 2015; +127%in local currency terms and -66% in US dollar terms Forecast in line with last quarter

- Healthcare: KZT176trn (USD978bn) in 2014 to KZT205trn (USD945bn) in 2015; +166% in localcurrency terms and -34% in US dollar terms Forecast in line with last quarter

Table Of Contents

Kazakhstan Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kazakhstan 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019) 17
Prescription Drug Market 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2013-2019) 30
Industry Risk Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q1 2016 31
Kazakhstan Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Clinical Trials 50
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Table: Multinational Market Activity 58
Pharmaceutical Distribution 58
Pharmaceutical Retail Sector 60
Company Profile 61
Chimpharm 61
Romat 63
Demographic Forecast 65
Demographic Outlook 65
Table: Population Headline Indicators (Kazakhstan 1990-2025) 66
Table: Key Population Ratios (Kazakhstan 1990-2025) 66
Table: Urban/Rural Population and Life Expectancy (Kazakhstan 1990-2025) 67
Table: Population By Age Group (Kazakhstan 1990-2025) 67
Table: Population By Age Group % (Kazakhstan 1990-2025) 68
Glossary 70
Methodology 72
Pharmaceutical Expenditure Forecast Model 72
Healthcare Expenditure Forecast Model 72
Notes On Methodology 73
Risk/Reward Index Methodology 74
Index Overview 75
Table: Pharmaceutical Risk/Reward Index Indicators 75
Indicator Weightings 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.